Lack of efficacy of recombinant human thyrotropin versus thyroid hormone withdrawal for radioiodine therapy imaging in a patient with differentiated thyroid carcinoma lung metastases

Thyroid

Volumn 14, Issue 6, 2004, Pages 465-467

  Taïeb, David ^a   Jacob, T ^a   Zotian, E ^a   Mundler, O ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RECOMBINANT THYROTROPIN; THYROTROPIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; FEMALE; HORMONE ACTION; HORMONE DEFICIENCY; HUMAN; HYPOTHYROIDISM; LIFE EXPECTANCY; LUNG METASTASIS; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID HORMONE WITHDRAWAL; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

ADULT; CARCINOMA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; RECOMBINANT PROTEINS; THYROID HORMONES; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; TREATMENT OUTCOME;

EID: 3042778360     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072504323150804     Document Type: Article

References (12)

1. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441.
2. 131I and recombinant human thyroid stimulating hormone. J Clin Endocrinol Metab 82:11-14.
3. Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C 2000 Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma. J Clin Endocrinol Metab 85:3640-3645.
4. Lippi F, Capezzone M, Angelini F, Taddei D, Molinaro E, Pinchera A, Pacini F 2001 Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH. Eur J Endocrinol 144:5-11.
5. Pellegriti G, Scollo C, Giuffrida D, Vigneri R, Squatrito S, Pezzino V 2001 Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer. Thyroid 11:1025-1030.
6. Berg G, Lindstedt G, Suurkula M, Jansson S 2002 Radioiodine ablation and therapy in differentiated thyroid cancer under stimulation with recombinant human thyroid-stimulating hormone. J Endocrinol Invest 25:44-52.
7. Pacini F, Molinaro E, Castagna MG, Lippi F, Ceccarelli C, Agate L, Elisei R, Pinchera A 2002 Ablation of thyroid residues with 30 mCi (131)I1: A comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 87:4063-4068.
8. Jarzab B, Handkiewicz-Junak D, Roskosz J, Puch Z, Wygoda Z, Kukulska A, Jurecka-Lubieniecka B, Hasse-Lazar K, Turska M, Zajusz A 2003 Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: A single-centre study of 54 patients. Eur J Nucl Med Mol Imaging 30:1077-1086.
9. Park SG, Reynolds JC, Bruker-Davis F, Whatley M, McEllin K, Marwted D, Robbins J, Weintraub BD 1996 Iodine kinetics during 1-131 scanning in patients with recombinant TSH (rhTSH) vs. hypothyroidism. J Nucl Med 37(suppl):15.
10. Menzel C, Kranert WT, Dobert N, Diehl M, Fietz T, Hamscho N, Berner U, Grunwald F 2003 rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of (131)I. J Nucl Med 44:1065-1068.
11. De Keizer B, Brans B, Hoekstra A, Zelissen PM, Koppeschaar HP, Lips CJ, Van Rijk PP, Dierckx RA, De Klerk JM 2003 Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy. Eur J Nucl Med Mol Imaging 30:367-373.
12. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD 1997 Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896.